Chemotherapy-induced myelotoxicity and incidence of lung metastasis in an animal model

Human and Experimental Toxicology

Volumn 30, Issue 7, 2011, Pages 649-655

  Son, Jin Young ^a   Shin, Jang Woo ^a   Wang, Jing Hua ^a   Park, Hye Jung ^a   Kim, Hyeong Geug ^a   Raghavendran, Hanumantha Rao Balaji ^a   Son, Chang Gue ^a  

^a Daejeon University   (South Korea)

Author keywords

5 fluorouracil; cancer; chemotherapy; Cisplatin; metastasis; myelotoxicity

Indexed keywords

CISPLATIN; FLUOROURACIL;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CANCER CELL; COLON CARCINOMA; DISEASE SEVERITY; LEUKOPENIA; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW; CELL LINE, TUMOR; CISPLATIN; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FLUOROURACIL; LEUKOPENIA; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL;

ANIMALIA; MURINAE; MUS;

EID: 79959735953     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110377521     Document Type: Article

References (19)

1. Kouroukis CT, Chia S., Verma S., Robson D., Desbiens C., Cripps C., et al. Canadian supportive care recommendations for the management of neutropenia in patients with cancer. Curr Oncol 2008 ; 15: 9-23.
2. Kuderer NM, Dale DC, Crawford J., Cosler LE, and Lyman GH Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006 ; 106: 2258-2266. (Pubitemid 43673249)
3. Minisini A., Spazzapan S., Crivellari D., Aapro M., and Biganzoli L. Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors. Crit Rev Oncol Hematol 2005 ; 53: 125-131. (Pubitemid 40127530)
4. Liotta LA, Kohn EC The microenvironment of the tumour-host interface. Nature 2001 ; 411: 375-379.
5. Molloy T., Van't Veer LJ Recent advances in metastasis research. Curr Opin Genet Dev 2008 ; 18: 35-41. (Pubitemid 351694450)
6. Suresh S. Biomechanics and biophysics of cancer cells. Acta Biomater 2007 ; 3: 413-438. (Pubitemid 46865787)
7. Rocconi RP, Matthews KS, Kemper MK, Hoskins KE, and Barnes MN Chemotherapy-related myelosuppression as a marker of survival in epithelial ovarian cancer patients. Gynecol Oncol 2008 ; 108: 336-341. (Pubitemid 351174291)
8. Pallis AG, Agelaki S., Kakolyris S., Kotsakis A., Kalykaki A., Vardakis N., et al. Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy. Lung Cancer 2008 ; 62: 356-363.
9. Freire-Garabal M., Núñez MJ, Riveiro P., Balboa J., López P., Zamorano BG, et al. Effects of fluoxetine on the activity of phagocytosis in stressed mice. Life Sci 2002 ; 72: 173-183. (Pubitemid 35356265)
10. Steeg PS, Theodorescu D. Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 2008 ; 5: 206-219. (Pubitemid 351493680)
11. Chambers AF, Groom AC, and MacDonald IC Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002 ; 2: 563-572. (Pubitemid 37328923)
12. Mayers C., Panzarella T., and Tannock IF Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma. Cancer 2001 ; 91: 2246-2257. (Pubitemid 32552809)
13. Poikonen P., Saarto T., Lundin J., Joensuu H., and Blomqvist C. Leukocyte nadir as a marker for chemotherapy efficacy in nodepositive breast cancer treated with adjuvant CMF. Br J Cancer 1999 ; 80: 1763-1766. (Pubitemid 29389629)
14. Saarto T., Blomqvist C., Rissanen P., Auvinen A., and Elomaa I. Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer. Br J Cancer 1997 ; 75: 301-305. (Pubitemid 27019578)
15. Roth C., Rochlitz C., and Kourilsky P. Immune response against tumors. Adv Immunol 1994 ; 57: 281-351.
16. Gassmann P., Haier J. The tumor cell-host organ interface in the early onset of metastatic organ colonisation. J Clin Exp Metastasis 2008 ; 25: 171-181.
17. Balducci L. Myelosuppression and its consequences in elderly patients with cancer. Oncology (Williston Park) 2003 ; 17: 27-32.
18. Friberg LE, Henningsson A., Maas H., Nguyen L., and Karlsson MO Model of chemotherapy-induced myelosuppression with parameter consistency across drugs. J Clin Oncol 2002 ; 20: 4713-4721. (Pubitemid 36025290)
19. Standish LJ, Torkelson C., Hamill FA, Yim D., Hill-Force A., Fitzpatrick A., et al. Immune defects in breast cancer patients after radiotherapy. J Soc Integr Oncol 2008 ; 6: 110-121.